Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04766996 · ClinicalTrials.gov registry record · Phase 4
PROUD Study - Preventing Opioid Use Disorders
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 57
- Enrollment target
NCT04766996: Clinical Trial Phase 4 study, sponsored by Emory University.
NCT04766996 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 57 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04766996, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 57 participants
- Enrollment target
Study Summary
The objective of this study is to pilot an opioid free anesthetic protocol for patients undergoing total hip replacement.
Primary Outcome
Total post-operative opioid requirements (opioid dose) were calculated for participants receiving the non-opioid drug regimen, among participants who required post-operative opioid medication.
Interventions
- DRUG Pregabalin
- BEHAVIORAL Guided mindfulness exercises
- OTHER Self-administered aromatherapy
- DRUG Baby aspirin
- DRUG Tylenol/Acetaminophen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2021-12-27 |
| Phase | Phase 4 |
Why NCT04766996 stopped before completion
NCT04766996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 5 interventions - of which Pregabalin is the first listed.
NCT04766996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04766996 about?
NCT04766996 is a clinical study titled "PROUD Study - Preventing Opioid Use Disorders". The objective of this study is to pilot an opioid free anesthetic protocol for patients undergoing total hip replacement.
What is the current status of trial NCT04766996?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 57 participants. The study started on 2021-05-17. Estimated completion is 2021-12-27.
What interventions are being tested in trial NCT04766996?
The interventions under investigation include: Pregabalin (DRUG), Guided mindfulness exercises (BEHAVIORAL), Self-administered aromatherapy (OTHER), Baby aspirin (DRUG), Tylenol/Acetaminophen (DRUG).
Who is sponsoring clinical trial NCT04766996?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04766996's enrollment target sits among peer trials
57 1209th of 2000 higher than 788 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI